Home > News > featured news > Komodo Health Introduces New Scientific Publications Management Software

HEALTH TECHNOLOGY

Komodo Health Introduces New Scientific Publications Management Software

Komodo Health | May 12, 2022

Komodo Health

Komodo Health announced the launch of Komodo Publications Planning, introducing the next generation of publications planning and management applications for Life Sciences. The automated and highly customizable end-to-end software is designed to make it easier to maximize the impact and outcome of scientific publications and medical communications in an accurate, efficient, and compliant manner. With today’s news, Komodo extends the power of its real-world data and technology for Medical Affairs professionals, offering a comprehensive suite of applications to manage all aspects of publications planning, including a more data-driven approach to engaging with healthcare providers.

In order to establish scientific integrity aligned to strategic medical objectives, global Medical Affairs teams are responsible for managing complex publication plans within Life Sciences companies, which can include both pipeline and commercial products or therapeutics with overlapping timelines. Multiple stakeholders need to seamlessly collaborate, provide feedback, and share updates with one another throughout the process, from publication concept through planning, and ultimately, publishing.

With out-of-the-box connectors to Altmetric, Office 365, Unpaywall, and the ability to seamlessly integrate and optimize existing technology workflows, Komodo Publications Planning provides the tools to address every aspect of planning, execution, and analysis in a consolidated view to bring speed and ease for Medical Affairs teams. The integrated, user-friendly workflow enhances productivity by helping customers reduce time spent managing tasks to allow more time to focus on producing high-quality publications.

For example, Pfizer was seeking a way to evolve and digitize how its publications were managed. The company developed a customized tool with Komodo Publications Planning as its foundation, which allowed Pfizer to roll out one cohesive publications management system that could be leveraged by a variety of stakeholders around the globe, creating a more efficient path for collaborating with authors and third-party agencies. With a consolidated view into its medical and scientific publication plans, Pfizer’s global team can automate the planning process, quickly tracking publication milestones and monitoring study progression using real-time alerts.

“Working in partnership with Komodo on designing and building a new publications management system has been an exciting and courageous journey. We were able to realize some of the innovative solutions we wanted to incorporate into our system to advance our publications practice,”

Catherine Skobe, MPH, Sr. Director, Publications Innovative Solutions Lead at Pfizer

“Legacy publications management applications often require long build cycles and offer limited control; Komodo Publications Planning is helping our customers eliminate the need for multiple, disjointed systems, which often cause timely and costly delays for publishing critical clinical advancements,” said Prasad Kanumury (PK), Mavens founder and General Manager at Komodo Health. “The ability to integrate into existing IT infrastructure is helping Medical Affairs teams to more effectively achieve their scientific objectives and produce timely, journal-accepted publications within a single, customizable solution.”

Stemming from the 2021 acquisition, Mavens' integration into Komodo has resulted in a number of new opportunities for enterprise impact. The release of Komodo Publications Planning marks the first new application within Komodo’s Medical Affairs Suite. The Medical Affairs Suite offers end-to-end workflow support on everything from optimizing publications, impact reporting, and clinical education to enabling HCPs with disease burden intelligence and advanced analytic solutions to build comprehensive, measurable, and evidence-based strategies. The suite also allows for strategic engagement opportunities through key expert identification within Komodo’s Aperture application, now with Medical Information Cloud integration, to encourage even more timely, compliant, and trackable clinical interactions.

The launch of Komodo Publications Planning coincides with the 18th Annual ISMPP Meeting, where experts from Komodo Health and Pfizer presented about the future evolution of the medical publications ecosystem in a session on May 9th. For more information, visit Komodo Health onsite at booth #14.

About Komodo Health

Komodo Health is a technology platform company creating the new standard for real-world data and analytics by pairing the industry’s most complete view of patient encounters with enterprise software and machine learning that connects the dots between individual patient journeys and large-scale health outcomes. Across Life Sciences, payer, provider, and developers, we help our customers unearth patient-centric insights at scale — marrying clinical data with advanced algorithms and AI-powered software solutions to inform decision making, close gaps in care, address disease burden, and help the enterprise create a more cost-effective, value-driven healthcare system.

Spotlight

GE Healthcare at Arab Health 2023

Whether online or in-person, Arab Health now means more meaningful meetings, more relevant content and more productive time.

More featured news

Spotlight

GE Healthcare at Arab Health 2023

Whether online or in-person, Arab Health now means more meaningful meetings, more relevant content and more productive time.

Related News

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

Charlie Health Introduces Virtual IOP Services in Florida

Charlie Health | January 18, 2023

On January 17, 2023, Charlie Health, the largest virtual intensive outpatient programming (IOP) provider for at-risk youth and families, announced its expansion into Florida. This comes at a time of need for the industry-leading mental health services the company offers. "As per NAMI Florida, one in six youths between the ages of six and seventeen experience a mental health disorder every year in Florida. Over half of the adolescents in the state suffering from depression cannot receive treatment due to geographical and financial barriers. Carter Barnhart, Co-Founder and CEO of Charlie Health (Mental Health America), said, "Over 6 million people in Florida live in communities that have a shortage of mental health professionals, demonstrating that it's more important than ever to find a viable solution to a limited system." She added, "Florida currently ranks 49th in the country for access to mental healthcare. We're going to change that. Our virtual IOP effectively eliminates long-standing barriers to care, providing young people and families in the state with evidence-based, life-saving treatment they can access from home." (Source – PR Newswire) This expansion of virtual IOP services in Florida follows the company's recent publication of a study on the effectiveness of virtual IOP. The study was completed in collaboration with the University of Pennsylvania. Based on data gathered over the course of nine months from 495 adolescent clients, researchers discovered a 71% reduction in suicidal ideation, a 60% reduction in depressive symptoms, and a 58% reduction in self-harm on discharge from Charlie Health's program. About Charlie Health Montana-based Charlie Health offers personalized treatment plans for adolescents, young adults, and families battling mental health and substance abuse disorders. The company's team of progressive, industry-leading professionals utilizes a customized approach to deliver evidence-based, comprehensive treatment programs. Charlie Health provides clients with the support they require for lifelong results via individual, group, and family therapy.

Read More

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

Body Vision Medical's Lungvision™ Validated by Xoran Technologies' Tron™ System

Body Vision Medical | February 15, 2023

Body Vision Medical, a leading AI-driven, intraoperative CT imaging provider, and Xoran Technologies, an innovator in low-dose, point-of-care CT systems, recently announced the successful validation of Body Vision's LungVisionTM system with Xoran's TRONTM system. The LungVisionTM system from Body Vision uses artificial intelligence (AI) to convert X-ray images from any C-arm into intraoperative, real-time CT scans. This enables bronchoscopists to obtain biopsies from smaller, harder-to-access lung lesions at an earlier stage, thereby improving lung cancer patients' chances of early diagnosis and survival. TRONTM is a mobile, full-body fluoroscopy, computed tomography (CT) X-ray system created to provide safe, ultra-high-resolution, low-dose imaging directly in point-of-care settings, including the surgery center, operating room, and critical care units, thus avoiding risky patient transport to Radiology for CT imaging, and aiding minimally invasive procedures (MIS). David Webster, CEO of Body Vision Medical, shared, "Body Vision's approach with LungVision™ is to ensure that it works with existing equipment so that we empower healthcare providers to better serve a growing population of lung patients without ballooning overall operating costs." He added, "While our rapidly growing installed base is real-world evidence that our technology integrates seamlessly with any 2D/3D X-ray imaging system, for customers seeking added assurance, this formal validation of Xoran TRON™ for use with LungVision™ is one of several steps we are proactively taking to ensure consistency in system performance regardless of setup." (Source – PR Newswire) About Body Vision Body Vision Medical is a commercial-stage medical device company founded in 2014 and based in Campbell, California. It specializes in real-time, intraoperative imaging powered by artificial intelligence. LungVisionTM, the company's first commercial product, addresses the unmet clinical requirement for early, definitive lung cancer diagnosis and, in the future, will enable minimally invasive treatment of lung lesions. In addition, the company continues to establish a new standard of care for lung diagnostics through the ongoing collaboration of physicians, clinical experts, and engineers with diverse backgrounds.

Read More

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

KARL STORZ Receives Innovative Technology Designation from Vizient for TIPCAM1 Rubina with ARTip SOLO Robotic Assistance

KARL STORZ | December 21, 2022

KARL STORZ Endoscopy-America, Inc., proudly announces its TIPCAM®1 Rubina® with ARTip® SOLO robotic assistance has received an Innovative Technology designation from Vizient, Inc., the largest healthcare performance improvement company in the country. KARL STORZ exhibited TIPCAM1 Rubina with ARTip SOLO at the Vizient Innovative Technology Exchange on Oct. 17 in Dallas, Texas. Each year, healthcare experts serving on Vizient member-led councils review select products and technologies for their potential to enhance clinical care, patient safety, and healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers that these innovations can have a positive impact on patient care and business models. TIPCAM1 Rubina is the only advanced endoscopic solution on the market that gives surgeons access to the most sophisticated visualization technologies of 4K imaging in 2D, 3D, and NIR/ICG, all in one video endoscope using ONE system, the KARL STORZ IMAGE1™ S. The ARTip SOLO robotic camera guidance system, paired with the TIPCAM1 Rubina, allows the operating surgeon to maintain stability and precise control of the field of view. This improves the environment to train surgeons on technical skills, enabling them to operate alone—which can improve efficiency, thereby lowering overall costs. It also provides ideal ergonomics, especially in long procedures. Advanced technologies such as 4K 3D and 4K NIR/ICG provide the ability to visualize crucial details during surgery, often resulting in improved safety and outcomes. 3D has shown to improve task completion time by 64% and reduce errors by 63% especially where suturing is involved. NIR/ICG can reduce complication rates through assessment of blood flow and visualization of critical anatomy. Due to the complexities in surgery, having access to different tools can give a surgeon confidence to properly assess and create a safe surgical plan. The unique combination of the TIPCAM1 Rubina and ARTip SOLO allows hospitals to bridge the gap between robotics and laparoscopy by recreating a robotic experience, incorporating advanced technologies that deliver value without the large capital expense. “KARL STORZ is committed to delivering quality products to allow for optimal surgical flow and advanced patient care. Desirable patient outcomes and improved surgeon ergonomics and autonomy, along with ease of setup enhancing operating room workflow, are just a few of the benefits offered by this innovative endoscopic solution. The advancement in imaging with streamlined robotic assistance allows for use across multiple surgical specialties, in both hospital and ambulatory care settings in rural and urban patient populations, providing equitable access to health care.” Aarathi Cholkeri-Singh, MD, Medical Director at KARL STORZ Endoscopy-America, Inc “Healthcare experts on Vizient member councils evaluated TIPCAM1 Rubina with ARTip SOLO robotic assistance as part of the Innovative Technology Program,” said Kelly Flaharty, Vizient Senior Director of Contract Services. “This designation indicates TIPCAM1 Rubina with ARTip SOLO robotic assistance has one or more qualities that differentiate it from similar products and has potential to make an incremental improvement in healthcare. Congratulations to KARL STORZ.” KARL STORZ Endoscopy-America, Inc., proudly announces its TIPCAM®1 Rubina® with ARTip® SOLO robotic assistance has received an Innovative Technology designation from Vizient, Inc., the largest healthcare performance improvement company in the country. KARL STORZ exhibited TIPCAM1 Rubina with ARTip SOLO at the Vizient Innovative Technology Exchange on Oct. 17 in Dallas, Texas. Each year, healthcare experts serving on Vizient member-led councils review select products and technologies for their potential to enhance clinical care, patient safety, and healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers that these innovations can have a positive impact on patient care and business models. TIPCAM1 Rubina is the only advanced endoscopic solution on the market that gives surgeons access to the most sophisticated visualization technologies of 4K imaging in 2D, 3D, and NIR/ICG, all in one video endoscope using ONE system, the KARL STORZ IMAGE1™ S. The ARTip SOLO robotic camera guidance system, paired with the TIPCAM1 Rubina, allows the operating surgeon to maintain stability and precise control of the field of view. This improves the environment to train surgeons on technical skills, enabling them to operate alone—which can improve efficiency, thereby lowering overall costs. It also provides ideal ergonomics, especially in long procedures. Advanced technologies such as 4K 3D and 4K NIR/ICG provide the ability to visualize crucial details during surgery, often resulting in improved safety and outcomes. 3D has shown to improve task completion time by 64% (44 of 69 studies) and reduce errors by 63% (28 of 45 studies), especially where suturing is involved. NIR/ICG can reduce complication rates through assessment of blood flow and visualization of critical anatomy. Due to the complexities in surgery, having access to different tools can give a surgeon confidence to properly assess and create a safe surgical plan. The unique combination of the TIPCAM1 Rubina and ARTip SOLO allows hospitals to bridge the gap between robotics and laparoscopy by recreating a robotic experience, incorporating advanced technologies that deliver value without the large capital expense. “KARL STORZ is committed to delivering quality products to allow for optimal surgical flow and advanced patient care. Desirable patient outcomes and improved surgeon ergonomics and autonomy, along with ease of setup enhancing operating room workflow, are just a few of the benefits offered by this innovative endoscopic solution,” said Aarathi Cholkeri-Singh, MD, Medical Director at KARL STORZ Endoscopy-America, Inc. “The advancement in imaging with streamlined robotic assistance allows for use across multiple surgical specialties, in both hospital and ambulatory care settings in rural and urban patient populations, providing equitable access to health care.” “Healthcare experts on Vizient member councils evaluated TIPCAM1 Rubina with ARTip SOLO robotic assistance as part of the Innovative Technology Program,” said Kelly Flaharty, Vizient Senior Director of Contract Services. “This designation indicates TIPCAM1 Rubina with ARTip SOLO robotic assistance has one or more qualities that differentiate it from similar products and has potential to make an incremental improvement in healthcare. Congratulations to KARL STORZ.” About Vizient Vizient represents a diverse membership that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks, and non-acute healthcare providers and represents approximately $130 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to healthcare. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle. About KARL STORZ KARL STORZ Endoscopy-America, Inc. is an innovative leader in endoscopic technology and imaging solutions across virtually all surgical specialties. KARL STORZ provides solutions that facilitate operational and workflow efficiencies across various sites of care, so healthcare providers can deliver optimal patient care in the most cost-effective manner. The group is an affiliate of KARL STORZ SE & Co. KG, an international leader and family-owned company based in Tuttlingen, Germany, that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness.

Read More

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

Charlie Health Introduces Virtual IOP Services in Florida

Charlie Health | January 18, 2023

On January 17, 2023, Charlie Health, the largest virtual intensive outpatient programming (IOP) provider for at-risk youth and families, announced its expansion into Florida. This comes at a time of need for the industry-leading mental health services the company offers. "As per NAMI Florida, one in six youths between the ages of six and seventeen experience a mental health disorder every year in Florida. Over half of the adolescents in the state suffering from depression cannot receive treatment due to geographical and financial barriers. Carter Barnhart, Co-Founder and CEO of Charlie Health (Mental Health America), said, "Over 6 million people in Florida live in communities that have a shortage of mental health professionals, demonstrating that it's more important than ever to find a viable solution to a limited system." She added, "Florida currently ranks 49th in the country for access to mental healthcare. We're going to change that. Our virtual IOP effectively eliminates long-standing barriers to care, providing young people and families in the state with evidence-based, life-saving treatment they can access from home." (Source – PR Newswire) This expansion of virtual IOP services in Florida follows the company's recent publication of a study on the effectiveness of virtual IOP. The study was completed in collaboration with the University of Pennsylvania. Based on data gathered over the course of nine months from 495 adolescent clients, researchers discovered a 71% reduction in suicidal ideation, a 60% reduction in depressive symptoms, and a 58% reduction in self-harm on discharge from Charlie Health's program. About Charlie Health Montana-based Charlie Health offers personalized treatment plans for adolescents, young adults, and families battling mental health and substance abuse disorders. The company's team of progressive, industry-leading professionals utilizes a customized approach to deliver evidence-based, comprehensive treatment programs. Charlie Health provides clients with the support they require for lifelong results via individual, group, and family therapy.

Read More

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

Body Vision Medical's Lungvision™ Validated by Xoran Technologies' Tron™ System

Body Vision Medical | February 15, 2023

Body Vision Medical, a leading AI-driven, intraoperative CT imaging provider, and Xoran Technologies, an innovator in low-dose, point-of-care CT systems, recently announced the successful validation of Body Vision's LungVisionTM system with Xoran's TRONTM system. The LungVisionTM system from Body Vision uses artificial intelligence (AI) to convert X-ray images from any C-arm into intraoperative, real-time CT scans. This enables bronchoscopists to obtain biopsies from smaller, harder-to-access lung lesions at an earlier stage, thereby improving lung cancer patients' chances of early diagnosis and survival. TRONTM is a mobile, full-body fluoroscopy, computed tomography (CT) X-ray system created to provide safe, ultra-high-resolution, low-dose imaging directly in point-of-care settings, including the surgery center, operating room, and critical care units, thus avoiding risky patient transport to Radiology for CT imaging, and aiding minimally invasive procedures (MIS). David Webster, CEO of Body Vision Medical, shared, "Body Vision's approach with LungVision™ is to ensure that it works with existing equipment so that we empower healthcare providers to better serve a growing population of lung patients without ballooning overall operating costs." He added, "While our rapidly growing installed base is real-world evidence that our technology integrates seamlessly with any 2D/3D X-ray imaging system, for customers seeking added assurance, this formal validation of Xoran TRON™ for use with LungVision™ is one of several steps we are proactively taking to ensure consistency in system performance regardless of setup." (Source – PR Newswire) About Body Vision Body Vision Medical is a commercial-stage medical device company founded in 2014 and based in Campbell, California. It specializes in real-time, intraoperative imaging powered by artificial intelligence. LungVisionTM, the company's first commercial product, addresses the unmet clinical requirement for early, definitive lung cancer diagnosis and, in the future, will enable minimally invasive treatment of lung lesions. In addition, the company continues to establish a new standard of care for lung diagnostics through the ongoing collaboration of physicians, clinical experts, and engineers with diverse backgrounds.

Read More

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

KARL STORZ Receives Innovative Technology Designation from Vizient for TIPCAM1 Rubina with ARTip SOLO Robotic Assistance

KARL STORZ | December 21, 2022

KARL STORZ Endoscopy-America, Inc., proudly announces its TIPCAM®1 Rubina® with ARTip® SOLO robotic assistance has received an Innovative Technology designation from Vizient, Inc., the largest healthcare performance improvement company in the country. KARL STORZ exhibited TIPCAM1 Rubina with ARTip SOLO at the Vizient Innovative Technology Exchange on Oct. 17 in Dallas, Texas. Each year, healthcare experts serving on Vizient member-led councils review select products and technologies for their potential to enhance clinical care, patient safety, and healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers that these innovations can have a positive impact on patient care and business models. TIPCAM1 Rubina is the only advanced endoscopic solution on the market that gives surgeons access to the most sophisticated visualization technologies of 4K imaging in 2D, 3D, and NIR/ICG, all in one video endoscope using ONE system, the KARL STORZ IMAGE1™ S. The ARTip SOLO robotic camera guidance system, paired with the TIPCAM1 Rubina, allows the operating surgeon to maintain stability and precise control of the field of view. This improves the environment to train surgeons on technical skills, enabling them to operate alone—which can improve efficiency, thereby lowering overall costs. It also provides ideal ergonomics, especially in long procedures. Advanced technologies such as 4K 3D and 4K NIR/ICG provide the ability to visualize crucial details during surgery, often resulting in improved safety and outcomes. 3D has shown to improve task completion time by 64% and reduce errors by 63% especially where suturing is involved. NIR/ICG can reduce complication rates through assessment of blood flow and visualization of critical anatomy. Due to the complexities in surgery, having access to different tools can give a surgeon confidence to properly assess and create a safe surgical plan. The unique combination of the TIPCAM1 Rubina and ARTip SOLO allows hospitals to bridge the gap between robotics and laparoscopy by recreating a robotic experience, incorporating advanced technologies that deliver value without the large capital expense. “KARL STORZ is committed to delivering quality products to allow for optimal surgical flow and advanced patient care. Desirable patient outcomes and improved surgeon ergonomics and autonomy, along with ease of setup enhancing operating room workflow, are just a few of the benefits offered by this innovative endoscopic solution. The advancement in imaging with streamlined robotic assistance allows for use across multiple surgical specialties, in both hospital and ambulatory care settings in rural and urban patient populations, providing equitable access to health care.” Aarathi Cholkeri-Singh, MD, Medical Director at KARL STORZ Endoscopy-America, Inc “Healthcare experts on Vizient member councils evaluated TIPCAM1 Rubina with ARTip SOLO robotic assistance as part of the Innovative Technology Program,” said Kelly Flaharty, Vizient Senior Director of Contract Services. “This designation indicates TIPCAM1 Rubina with ARTip SOLO robotic assistance has one or more qualities that differentiate it from similar products and has potential to make an incremental improvement in healthcare. Congratulations to KARL STORZ.” KARL STORZ Endoscopy-America, Inc., proudly announces its TIPCAM®1 Rubina® with ARTip® SOLO robotic assistance has received an Innovative Technology designation from Vizient, Inc., the largest healthcare performance improvement company in the country. KARL STORZ exhibited TIPCAM1 Rubina with ARTip SOLO at the Vizient Innovative Technology Exchange on Oct. 17 in Dallas, Texas. Each year, healthcare experts serving on Vizient member-led councils review select products and technologies for their potential to enhance clinical care, patient safety, and healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers that these innovations can have a positive impact on patient care and business models. TIPCAM1 Rubina is the only advanced endoscopic solution on the market that gives surgeons access to the most sophisticated visualization technologies of 4K imaging in 2D, 3D, and NIR/ICG, all in one video endoscope using ONE system, the KARL STORZ IMAGE1™ S. The ARTip SOLO robotic camera guidance system, paired with the TIPCAM1 Rubina, allows the operating surgeon to maintain stability and precise control of the field of view. This improves the environment to train surgeons on technical skills, enabling them to operate alone—which can improve efficiency, thereby lowering overall costs. It also provides ideal ergonomics, especially in long procedures. Advanced technologies such as 4K 3D and 4K NIR/ICG provide the ability to visualize crucial details during surgery, often resulting in improved safety and outcomes. 3D has shown to improve task completion time by 64% (44 of 69 studies) and reduce errors by 63% (28 of 45 studies), especially where suturing is involved. NIR/ICG can reduce complication rates through assessment of blood flow and visualization of critical anatomy. Due to the complexities in surgery, having access to different tools can give a surgeon confidence to properly assess and create a safe surgical plan. The unique combination of the TIPCAM1 Rubina and ARTip SOLO allows hospitals to bridge the gap between robotics and laparoscopy by recreating a robotic experience, incorporating advanced technologies that deliver value without the large capital expense. “KARL STORZ is committed to delivering quality products to allow for optimal surgical flow and advanced patient care. Desirable patient outcomes and improved surgeon ergonomics and autonomy, along with ease of setup enhancing operating room workflow, are just a few of the benefits offered by this innovative endoscopic solution,” said Aarathi Cholkeri-Singh, MD, Medical Director at KARL STORZ Endoscopy-America, Inc. “The advancement in imaging with streamlined robotic assistance allows for use across multiple surgical specialties, in both hospital and ambulatory care settings in rural and urban patient populations, providing equitable access to health care.” “Healthcare experts on Vizient member councils evaluated TIPCAM1 Rubina with ARTip SOLO robotic assistance as part of the Innovative Technology Program,” said Kelly Flaharty, Vizient Senior Director of Contract Services. “This designation indicates TIPCAM1 Rubina with ARTip SOLO robotic assistance has one or more qualities that differentiate it from similar products and has potential to make an incremental improvement in healthcare. Congratulations to KARL STORZ.” About Vizient Vizient represents a diverse membership that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks, and non-acute healthcare providers and represents approximately $130 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to healthcare. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle. About KARL STORZ KARL STORZ Endoscopy-America, Inc. is an innovative leader in endoscopic technology and imaging solutions across virtually all surgical specialties. KARL STORZ provides solutions that facilitate operational and workflow efficiencies across various sites of care, so healthcare providers can deliver optimal patient care in the most cost-effective manner. The group is an affiliate of KARL STORZ SE & Co. KG, an international leader and family-owned company based in Tuttlingen, Germany, that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness.

Read More

More featured news